The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Chad Dodd, vice president of product management at athenahealth, sat down with MobiHealthNews to discuss Ambient Notes and how the company's AI-enabled products have evolved.
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.